KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Operating Expenses (2016 - 2026)

Medtronic's Operating Expenses history spans 13 years, with the latest figure at $3.7 billion for Q1 2026.

  • For Q1 2026, Operating Expenses rose 6.98% year-over-year to $3.7 billion; the TTM value through Jan 2026 reached $14.6 billion, up 5.0%, while the annual FY2025 figure was $13.8 billion, 1.1% up from the prior year.
  • Operating Expenses for Q1 2026 was $3.7 billion at Medtronic, down from $3.7 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.7 billion in Q4 2025 and bottomed at $3.2 billion in Q1 2022.
  • The 5-year median for Operating Expenses is $3.4 billion (2023), against an average of $3.5 billion.
  • The largest YoY upside for Operating Expenses was 7.12% in 2025 against a maximum downside of 0.03% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $3.3 billion in 2022, then grew by 3.01% to $3.4 billion in 2023, then grew by 1.78% to $3.5 billion in 2024, then grew by 7.12% to $3.7 billion in 2025, then dropped by 1.45% to $3.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Operating Expenses are $3.7 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.6 billion (Q3 2025).